medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2023, Número 4

<< Anterior Siguiente >>

Acta Pediatr Mex 2023; 44 (4)


Lactante masculino con inmunodeficiencia combinada grave

Ramírez RAG, Yamazaki NMA, Sarmiento AMA

Idioma: Español
Referencias bibliográficas: 28
Paginas: 297-311
Archivo PDF: 586.58 Kb.


FRAGMENTO

RESUMEN CLÍNICO

Paciente masculino que falleció a la edad de ocho meses, hijo de padres aparentemente sanos, con antecedente de muertes, en la primera infancia, de niños varones de la línea materna. Su último padecimiento se inició a los 6 a 7 meses de vida, con un cuadro catarral caracterizado por rinorrea y coriza. Por este motivo fue llevado a consulta con un médico particular, quien le prescribió amoxicilina durante cinco días. Al cuadro catarral se agregaron: tos no productiva, irritabilidad, fiebre y evacuaciones disminuidas en consistencia. Fue llevado al Instituto Nacional de Pediatría debido a los síntomas y cumplir con criterios de sospecha de COVID-19. El paciente recibió la vacuna BCG al nacimiento.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L,Al-Herz W, et al. The 2022 Update of IUIS PhenotypicalClassification for Human Inborn Errors of Immunity. J ClinImmunol 2022; 42 (7): 1508-520.

  2. Bustamante Ogando JC, Partida Gaytán A, Aldave BecerraJC, Álvarez Cardona A, Bezrodnik L, Borzutzky A, BlancasGalicia L, et al. Latin American consensus on the supportivemanagement of patients with severe combined immunodeficiency.J Allergy Clin Immunol 2019; 144 (4): 897-905.

  3. Stephanie Ryan, Michelle McNicolas, Stephen J. Eustace.Torax, en Anatomía para el diagnóstico por imagen. Madrid:Marban, 2013.

  4. Gilbert-Barness E, Kapur RP. Thymus, Spleen, Lymphoid,Tissues and Immunodeficency disorders. En: Potter´sPathology of the Fetus, Infant and Child. 2th ed. Elsevier,2007; 1538.

  5. Glanzmann E, Riniker P. Essentielle lymphocytophthise. Einneues Krankenheitzbild aus der Sanglings-pathologie. AnnPaediatr (Basel) 1950; 175: 1-32.

  6. Hitzig WH, Biro Z, Bosch H. Agammaglobulinemia & alymphocytosiswith atrophy of lymphatic tissue. Helv PaediatrActa 1958; 13: 551-85.

  7. Tobler R, Cottier H. Familial lymphopenia with agammaglobulinemia& severe moniliasis: the essentiallymphocytophthisis as a special form of early childhoodagammaglobulinemia. Helv Paediatr Acta 1958; 13: 313-38.

  8. Nezelof C, Jammet ML, Lortholary P, Labrune B, Lamy M.L’hypoplasie Hereditaire du thymus. Sa place et sa responsibilitedans une observation d’aplasie lymphocytake normoplasmocytaireet normoglobulinemique du nourrisson.Arch Fr Pediatr 1964; 21: 897-920.

  9. Gosseye S, Diebold N, Griscelli C, Nezelof C. Severe combinedimmunodeficiency disease: a pathological analysis of26 cases. Clin. Zmmunol. Immunopathol 1983; 28; 58-77.

  10. Meuwissen HJ, Pollara B, Pickering RJ. Combined immunodeficiencydisease associated with adenosine deaminasedeficiency. Report on a Workshop Held in Albany, New York,October 1, 1973. Pediatrics 1975; 86 (2): 169-81.

  11. Ratech H, Hirschhorn R, Greco MA. Pathologic findingsin adenosine deaminase deficient-severe combined immunodeficiency.II. Thymus, spleen, lymph node, andgastrointestinal tract lymphoid tissue alterations. Am JPathol 1989; 135 (6): 1145-56.

  12. Tasher D, Dalal I. The genetic basis of severe combinedimmunodeficiency and its variants. Appl Clin Genet 2012;5: 67-80.

  13. Sugamura K, Asao H, Kondo M, Tanaka N, Ishii N, Ohbo K,et al The interleukin-2 receptor gamma chain: its role inthe multiple cytokine receptor complexes and T cell developmentin xSCID. Annu Rev Immunol 1996; 14: 179-205.

  14. Kovanen PE, Leonard WJ. Cytokines and immunodeficiencydiseases: Critical roles of the gamma(c)-dependent cytokinesinterleukins 2, 4, 7, 9, 15, and 21, and their signalingpathways. Immunol Rev 2004; 202: 67-83.

  15. Rochman Y, Spolski R, Leonard WJ. New insights into theregulation of T cells by gamma(c) family cytokines. Nat RevImmunol 2009; 9 (7): 480-90.

  16. O’Shea JJ, Notarangelo LD, Johnston JA, Candotti F. Advancesin the understanding of cytokine signal transduction:The role of Jaks and STATs in immunoregulation andthe pathogenesis of immunodeficiency. J Clin Immunol1997; 17 (6): 431-47.

  17. Hershfield MS. Genotype is an important determinant ofphenotype in adenosine deaminase deficiency. Curr OpinImmunol 2003; 15 (5): 571-77.

  18. Resta R, Thompson LF. SCID: the role of adenosine deaminasedeficiency. Immunol Today 1997; 18 (8): 371-74.

  19. Lagresle-Peyrou C, Six EM, Picard C, Rieux-Laucat F, MichelV, Ditadi A, et al. Human adenylate kinase 2 deficiencycauses a profound hematopoietic defect associated withsensorineural deafness. Nat Genet 2009; 41 (1): 106-111.

  20. Nicolas N, Moshous D, Cavazzana-Calvo M, PapadopouloD, de Chasseval R, Le Deist F, et al. A human severe combinedimmunodeficiency (IDCG) condition with increasedsensitivity to ionizing radiations and impaired V(D)J rearrangementsdefines a new DNA recombination/repairdeficiency. J Exp Med 1998; 188 (4): 627-634.

  21. de Villartay JP. V(D)J recombination deficiencies. Adv ExpMed Biol 2009; 650: 46-58. doi: 10.1007/978-1-4419-0296-2_4

  22. Puck JM. Newborn screening for severe combined immunodeficiencyand T-cell lymphopenia. Immunol Rev 2019;287 (1): 241-52.

  23. Bollée G, Sarfati C, Thiéry G, Bergeron A, de Miranda S,Menotti J, et al. Clinical Picture of Pneumocystis jiroveciiPneumonia in Cancer Patients. Chest 2007; 132: 1305-10.

  24. Toma P, Bertaina A, Castagnola E, Colafati GS, D'Andrea ML,Finocchi A, et al . Fungal infections of the lung in children.Pediatr Radiol 2016; 46 (13): 1856-65.

  25. Vogel MN, Vatlach M, Weissgerber P, Goeppert B, ClaussenCD, Hetzel J. et al. HRCT-features of Pneumocystis jiroveciipneumonia and their evolution before and after treatmentin non-HIV immunocompromised patients. Eur J Radiol2012; 81 (6): 1315-20.

  26. Luna MA, Cleary KR. Spectrum of pathologic manifestationsof Pneumocystis carinii pneumonia in patients with neoplasticdiseases. Semin Diagn Pathol 1989; 6 (3): 262-72.

  27. Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP,Berry CC. et al. Efficacy of gene therapy for X-linked severecombined immunodeficiency. N Engl J Med 2010;363 (4): 355-64.

  28. Ferrua F, Brigida I, Aiuti A. Update on gene therapy for adenosinedeaminase-deficient severe combined immunodeficiency.Curr Opin Allergy Clin Immunol 2010; 10 (6): 551-56.




2020     |     www.medigraphic.com